English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3bold beta activity

Trivedi, C. M., Luo, Y., Yin, Z., Zhang, M., Zhu, W., Wang, T., et al. (2007). Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3bold beta activity. Nature Medicine, 13(3), 324-331. doi:10.1038/nm1552.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : Nat Med

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Trivedi, Chinmay M., Author
Luo, Yang, Author
Yin, Zhan, Author
Zhang, Maozhen, Author
Zhu, Wenting, Author
Wang, Tao, Author
Floss, Thomas, Author
Goettlicher, Martin, Author
Ruiz Noppinger, Patricia1, Author
Wurst, Wolfgang, Author
Ferrari, Victor A., Author
Abrams, Charles S., Author
Gruber, Peter J., Author
Epstein, Jonathan A., Author
Affiliations:
1Max Planck Society, ou_persistent13              

Content

show
hide
Free keywords: -
 Abstract: In the adult heart, a variety of stresses induce re-expression of a fetal gene program in association with myocyte hypertrophy and heart failure. Here we show that histone deacetylase-2 (Hdac2) regulates expression of many fetal cardiac isoforms. Hdac2 deficiency or chemical histone deacetylase (HDAC) inhibition prevented the re-expression of fetal genes and attenuated cardiac hypertrophy in hearts exposed to hypertrophic stimuli. Resistance to hypertrophy was associated with increased expression of the gene encoding inositol polyphosphate-5-phosphatase f (Inpp5f) resulting in constitutive activation of glycogen synthase kinase 3beta (Gsk3beta) via inactivation of thymoma viral proto-oncogene (Akt) and 3-phosphoinositide-dependent protein kinase-1 (Pdk1). In contrast, Hdac2 transgenic mice had augmented hypertrophy associated with inactivated Gsk3beta. Chemical inhibition of activated Gsk3beta allowed Hdac2-deficient adults to become sensitive to hypertrophic stimulation. These results suggest that Hdac2 is an important molecular target of HDAC inhibitors in the heart and that Hdac2 and Gsk3beta are components of a regulatory pathway providing an attractive therapeutic target for the treatment of cardiac hypertrophy and heart failure.

Details

show
hide
Language(s): eng - English
 Dates: 2007-03
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: -
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Nature Medicine
  Alternative Title : Nat Med
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 13 (3) Sequence Number: - Start / End Page: 324 - 331 Identifier: ISSN: 1078-8956